stoxline Quote Chart Rank Option Currency Glossary
  
Know Labs, Inc. (KNW)
0.6201  -0.018 (-2.81%)    03-28 10:31
Open: 0.6189
High: 0.64
Volume: 4,204
  
Pre. Close: 0.638
Low: 0.6189
Market Cap: 50(M)
Technical analysis
2024-03-28 10:17:22 AM
Short term     
Mid term     
Targets 6-month :  0.87 1-year :  1.07
Resists First :  0.74 Second :  0.92
Pivot price 0.66
Supports First :  0.46 Second :  0.39
MAs MA(5) :  0.64 MA(20) :  0.7
MA(100) :  0.53 MA(250) :  0.7
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  17.1 D(3) :  16.1
RSI RSI(14): 48.8
52-week High :  1.48 Low :  0.23
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ KNW ] has closed above bottom band by 25.1%. Bollinger Bands are 64.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.66 - 0.66 0.66 - 0.67
Low: 0.59 - 0.6 0.6 - 0.6
Close: 0.63 - 0.64 0.64 - 0.64
Company Description

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Headline News

Wed, 20 Mar 2024
Know Labs initiates at-the-market stock offering program By Investing.com - Investing.com

Fri, 08 Mar 2024
Know Labs (NYSEAMERICAN:KNW) Shares Down 11.1% - Defense World

Wed, 06 Mar 2024
Know Labs Reports Promising Results from Clinical Study - TipRanks.com - TipRanks

Wed, 06 Mar 2024
Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study - Business Wire

Thu, 29 Feb 2024
Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and ... - Business Wire

Thu, 29 Feb 2024
Know Labs secures $12 million investment from Lind By Investing.com - Investing.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Technology
Industry:
Scientific & Technical Instruments
Shares Out 80 (M)
Shares Float 35 (M)
Held by Insiders 32.2 (%)
Held by Institutions 3.5 (%)
Shares Short 544 (K)
Shares Short P.Month 745 (K)
Stock Financials
EPS -0.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -155.9 %
Return on Equity (ttm) -636.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0.05
Sales Per Share 0
EBITDA (p.s.) -0.22
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -1.31
PEG Ratio 0
Price to Book value 63.99
Price to Sales 0
Price to Cash Flow -4.22
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android